JP2023509187A5 - - Google Patents
Info
- Publication number
- JP2023509187A5 JP2023509187A5 JP2022541987A JP2022541987A JP2023509187A5 JP 2023509187 A5 JP2023509187 A5 JP 2023509187A5 JP 2022541987 A JP2022541987 A JP 2022541987A JP 2022541987 A JP2022541987 A JP 2022541987A JP 2023509187 A5 JP2023509187 A5 JP 2023509187A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- sequence shown
- acid sequence
- pharmaceutical composition
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20150738 | 2020-01-08 | ||
| EP20150738.1 | 2020-01-08 | ||
| PCT/EP2021/050168 WO2021140140A1 (en) | 2020-01-08 | 2021-01-07 | Compound and method for treatment of alzheimer's disease |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023509187A JP2023509187A (ja) | 2023-03-07 |
| JP2023509187A5 true JP2023509187A5 (https=) | 2024-01-30 |
| JP7820821B2 JP7820821B2 (ja) | 2026-02-26 |
Family
ID=69156193
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022541987A Active JP7820821B2 (ja) | 2020-01-08 | 2021-01-07 | アルツハイマー病の治療のための化合物及び方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20230002458A1 (https=) |
| EP (1) | EP4087860B1 (https=) |
| JP (1) | JP7820821B2 (https=) |
| CN (1) | CN115943153A (https=) |
| WO (1) | WO2021140140A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024079221A1 (en) | 2022-10-12 | 2024-04-18 | Alphabeta Ab | The bri2 brichos domain for delivery of proteins into cns neurons |
| WO2025078660A1 (en) | 2023-10-11 | 2025-04-17 | Alphabeta Ab | The bri2 brichos domain for treatment of parkinson´s disease |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000058353A1 (en) * | 1998-12-10 | 2000-10-05 | Shanghai Second Medical University | Npcahh01: human transmembrane protein e3-16 gene |
| WO2006138355A2 (en) * | 2005-06-14 | 2006-12-28 | Albert Einstein College Of Medicine Of Yeshiva University | Effect of bri proteins on abeta production |
| AU2010356144B2 (en) | 2010-06-24 | 2015-06-04 | Alphabeta Ab | Compound and method for treatment of Alzheimer's disease and familial dementia |
| WO2012138284A1 (en) | 2011-04-05 | 2012-10-11 | Alphabeta Ab | Amyloidosis target useful in methods of treatment and for screening of compounds |
-
2021
- 2021-01-07 US US17/784,591 patent/US20230002458A1/en active Pending
- 2021-01-07 JP JP2022541987A patent/JP7820821B2/ja active Active
- 2021-01-07 EP EP21700377.1A patent/EP4087860B1/en active Active
- 2021-01-07 WO PCT/EP2021/050168 patent/WO2021140140A1/en not_active Ceased
- 2021-01-07 CN CN202180008401.XA patent/CN115943153A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023506765A5 (https=) | ||
| CN102224168B (zh) | 用于生产抗淀粉状蛋白β肽抗体的含有D-肽的组合物 | |
| JPWO2019156137A5 (https=) | ||
| CA2529179A1 (en) | Recombinant adeno-associated virus vector for treatment of alzheimer disease | |
| JP2006516116A5 (https=) | ||
| TW201629085A (zh) | 芋螺毒素（ｃｏｎｏｔｏｘｉｎ）肽之修飾及用途 | |
| JP2023509187A5 (https=) | ||
| JP2002206000A5 (https=) | ||
| JP2009525323A (ja) | 神経変性疾患の処置の為にｔｌｒ３アゴニストを使用する方法 | |
| CN102099372A (zh) | 抗淀粉样蛋白免疫原性组合物、方法和应用 | |
| JP2023535121A5 (https=) | ||
| JP2006502702A5 (https=) | ||
| JP2022509445A5 (https=) | ||
| JP2007535910A5 (https=) | ||
| JP2020535161A5 (https=) | ||
| RU2019136495A (ru) | C-концевые фрагменты cdnf и маnf, фармацевтические композиции, содержащие указанные фрагменты, и применения указанных фрагментов и композиций | |
| JP2023514659A5 (https=) | ||
| JP7428404B2 (ja) | Ｇｓｘ１を使用した脊髄損傷（ｓｃｉ）および脳損傷の処置 | |
| JP2024525213A5 (https=) | ||
| US20180170983A1 (en) | New Use of Cell-Permeable Peptide Inhibitors of the JNK Signal Transduction Pathway for the Treatment of Mild Cognitive Impairment | |
| RU2010141916A (ru) | Растворимый мутант рецептора фактора некроза опухоли | |
| JP2013535965A5 (https=) | ||
| JP2022530068A5 (https=) | ||
| JP2009517009A5 (https=) | ||
| CN101300031A (zh) | 用sdf-1治疗和/或预防神经疾病 |